Glyphic Biotechnologies
Next Generation Protein Sequencing
Berkeley, United States · Founded 2021 · $44.1M raised
- Headquarters
- Berkeley, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- glyphic.bio
- Total Funding
- $44.1M
- Last Round
- $2.9M Series ASep 2025
- Rounds
- 7
About
Founded in 2021 and headquartered in Berkeley, California, Glyphic Biotechnologies exists to fundamentally rewrite the rules of proteomics. The company is developing Protein Sequencing by Expansion (ProSE™), the first truly de novo high-throughput proteome sequencing technology capable of discriminating all 20 amino acids and post-translational modifications with single-molecule sensitivity. Glyphic's platform leverages spatial expansion of amino acids to enable massively parallel proteome sequencing, unlocking critical first-in-class therapies and deeper insights into biology.
Summary
Glyphic Biotechnologies is a Biotech company based in Berkeley, United States, founded in 2021. It has raised $44.1M in total across 7 rounds, most recently a $2.9M Series A round in Sep 2025. Investors include OMX Ventures and Osage University Partners.
Tech & App Stack
20 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2025
Sign up to see all 7 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Therapeutics company working in drug discovery and development using fungi with genomics approach...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/glyphic-biotechnologies"><img src="https://indexed.vc/api/badge/company/glyphic-biotechnologies" alt="Glyphic Biotechnologies on Indexed.vc" width="260" height="76" /></a>